Two-fold illumination in topical 5-aminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) for superficial basal cell carcinoma (sBCC): A retrospective case series and cohort study - 14/04/16
, Jolanda Hendriks, BSc d, Patty Nelemans, MD, PhD b, Klara Mosterd, MD, PhD a, c, Nicole Kelleners-Smeets, MD, PhD a, c, eAbstract |
Background |
There is limited literature on efficacy using a 2-fold illumination scheme in aminolevulinic acid (ALA) photodynamic therapy for superficial basal cell carcinoma (sBCC).
Objectives |
We sought to determine the efficacy of ALA photodynamic therapy for sBCC using a 2-fold illumination scheme after a single ALA application. Treatment failure within 12 months posttreatment was assessed.
Methods |
In this retrospective case series and cohort study, electronic files from patients treated between January 2010 and August 2011 were reviewed. Follow-up data were gathered until March 2014.
Results |
A total of 323 sBCC were analyzed for recurrence. Cumulative probability of clinical recurrence-free survival was 88.8% (95% confidence interval [CI] 85.4-92.4), 81.8% (95% CI 77.3-86.3), and 77.1% (95% CI 71.0-83.6) at 12, 24, and 48 months, respectively. For histologically confirmed recurrences this was 90.2% (95% CI 86.9-93.5), 85.4% (95% CI 75.5-89.3), and 81.8% (95% CI 75.5-88.1), respectively. A worse recurrence-free survival for tumors in the head and neck area and tumors larger than 10 mm was observed.
Limitations |
The retrospective nature and the lack of a control group are limitations.
Conclusions |
ALA photodynamic therapy using a 2-fold illumination scheme might be a feasible treatment option with acceptable long-term results for small sBCC located outside the head and neck area.
Le texte complet de cet article est disponible en PDF.Key words : efficacy, 5-aminolevulinic acid, methyl aminolevulinic acid, photodynamic therapy, treatment protocol
Abbreviations used : ALA, BCC, CI, CR, HR, MAL, PDT, sBCC
Plan
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
Vol 74 - N° 5
P. 899-906 - mai 2016 Retour au numéro
Article précédent
- Pyoderma gangrenosum (PG) associated with levamisole-adulterated cocaine: Clinical, serologic, and histopathologic findings in a cohort of patients
- Haneol S. Jeong, Heather Layher, Lauren Cao, Travis Vandergriff, Arturo R. Dominguez
- The efficacy of 308-nm excimer laser/light (EL) and topical agent combination therapy versus EL monotherapy for vitiligo: A systematic review and meta-analysis of randomized controlled trials (RCTs)
- Jung Min Bae, Bo Young Hong, Joo Hee Lee, Ji Hae Lee, Gyong Moon Kim
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?